Advanced Biomed (ADVB) Capital Expenditures (2024 - 2026)

Advanced Biomed has reported Capital Expenditures for 3 years, with the latest figure at $1264.0 in Q1 2026.

• Quarterly Capital Expenditures fell 42.93% year-over-year to $1264.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87467.0 (up 233.58% YoY) and the FY2025 annual result came in at $83027.0, up 247.93% from the prior year.
• Capital Expenditures fell to $1264.0 in Q1 2026 per ADVB's latest filing, from $22934.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $71526.0 in Q2 2025 and troughed at -$76981.0 in Q2 2024.
• A 3-year average of -$523.56 and a median of $1264.0 in 2026 frame the typical range for Capital Expenditures.
• The widest YoY moves for Capital Expenditures: up 314.5% in 2025, down 141.33% in 2025.
• Over 3 years, Capital Expenditures stood at -$10692.0 in 2024, then surged by 314.5% to $22934.0 in 2025, then slumped by 94.49% to $1264.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $1264.0, $22934.0, and -$8257.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.